The PurpleLab^® Resource Center

Ovarian cancer accounts for more deaths than any other cancer of the female reproductive system. This illness often begins with little or no symptoms, meaning patients and their doctors discover it when it’s too late for preventative treatment. Conducting successful ovarian cancer clinical trials can help us uncover new treatments and save lives — but…

The investment highlights PurpleLab’s™ growing role in simplifying the access to and interpretation of Real-World Data (RWD) across the healthcare continuum.

We looked at three of the leading medications belonging to the Interleukin antagonists group used to treat this condition that specifically treat psoriasis: secukinumab, risankizumab, and ixekizumab.